pre-IPO PHARMA

COMPANY OVERVIEW

Enesi Pharma is a clinical-stage pharmaceutical company developing innovative drug-device combination products with potential to transform performance and delivery of vaccines and therapeutics and make a material impact on global healthcare


LOCATION

  • Abingdon, Oxfordshire, UK

  • THERAPEUTIC AREAS

  • Endocrine Disease
  • Infectious Disease
  • Women's Health

  • WEBSITE

    https://www.enesipharma.com/


    CAREER WEBSITE

    https://www.enesipharma.com/contact-us/work-for-us/


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Oct 19, 2021

    Enesi Pharma Enters Agreement with National Institutes of Health to Evaluate ImplaVax-enabled Flu Vaccines


    Sep 7, 2021

    Enesi Pharma appoints Elizabeth Eagling-Vose, MBA, as Senior Vice President, Operations


    May 6, 2021

    Enesi Pharma's ImplaVax-Enabled, Solid-Dose Recombinant Classical Swine Fever (CSF) Vaccine Produces Immune Responses Superior to Liquid Vaccine


    May 5, 2021

    Enesi Pharma Achieves Key Milestone in Development of Thermostable Solid-dose Live Vaccines against Measles and Rubella


    May 4, 2021

    Enesi Pharma Achieves Preclinical Proof-of-Concept with ImplaVax-Enabled Pandemic Influenza Vaccine


    For More Press Releases


    Google Analytics Alternative